UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study

Antimicrobial agents and chemotherapy, 2001-12, Vol.45 (12), p.3487-3496

2001

Volltextzugriff (PDF)

AmBisome (Liposomal Amphotericin B): A Comparative Review

Journal of clinical pharmacology, 1998-07, Vol.38 (7), p.583-592

1998

Volltextzugriff (PDF)

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.176-182

2001

Volltextzugriff (PDF)

Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

Antimicrobial Agents and Chemotherapy, 2001-12, Vol.45 (12), p.3322-3327

2001

Volltextzugriff (PDF)

Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children

Journal of the American Academy of Dermatology, 1998, Vol.38 (1), p.69-76

1998

Volltextzugriff (PDF)

Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (Ambisome®) : A 91-day study in Rats

Pharmaceutical research, 2000-12, Vol.17 (12), p.1494-1502

2000

Volltextzugriff (PDF)

Demographic Considerations in Tacrolimus Pharmacokinetics

Transplantation proceedings, 1998-06, Vol.30 (4), p.1359-1364

1998

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.828-833

2002

Volltextzugriff (PDF)

A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a Liposomal amphotericin B formulation

Therapeutic drug monitoring, 1996-10, Vol.18 (5), p.604-609

1996

Volltextzugriff (PDF)

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.834-840

2002

Volltextzugriff (PDF)

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Journal of clinical pharmacology, 1999-10, Vol.39 (10), p.1032-1037

1999

Volltextzugriff (PDF)

Withdrawal-Related Adverse Events from Clinical Trials of Clobazam in Lennox-Gastaut Syndrome (LGS) (P06.106)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.P06-P06.106

2012

Volltextzugriff (PDF)

Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1857-1869

2002

Volltextzugriff (PDF)

Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic

Seminars in cutaneous medicine and surgery, 2001-12, Vol.20 (4), p.226-232

2001

Volltextzugriff (PDF)

The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

Clinical pharmacology and therapeutics, 2001-01, Vol.69 (1), p.24-31

2001

Volltextzugriff (PDF)

Lipid-based amphotericin B formulations: from animals to man

Pharmaceutical Science & Technology Today, 1999-06, Vol.2 (6), p.230-236

1999

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963-971

2001

Volltextzugriff (PDF)

Tacrolimus pharmacokinetics in BMT patients

Bone marrow transplantation (Basingstoke), 1998, Vol.21 (1), p.23-28

1998

Volltextzugriff (PDF)

Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose

Journal of clinical pharmacology, 2001-03, Vol.41 (3), p.289-297

2001

Volltextzugriff (PDF)

Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients

Antimicrobial Agents and Chemotherapy, 1998-09, Vol.42 (9), p.2391-2398

1998

Volltextzugriff (PDF)

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

Clinical pharmacology and therapeutics, 1997-07, Vol.62 (1), p.41-49

1997

Volltextzugriff (PDF)

Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse

Transplantation proceedings, 1998-09, Vol.30 (6), p.2579-2581

1998

Volltextzugriff (PDF)

Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis

Journal of the American Academy of Dermatology, 2001-01, Vol.44 (1), p.S17-S27

2001

Volltextzugriff (PDF)

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients

Bone marrow transplantation (Basingstoke), 1997-07, Vol.20 (1), p.49-51

1997

Volltextzugriff (PDF)

FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse

Transplantation proceedings, 1998-06, Vol.30 (4), p.1039-1041

1998

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(150)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(90)
Male
(65)
Pharmacology & Pharmacy
(62)
Biological And Medical Sciences
(60)
Medical Sciences
(60)
Humans
(58)
Pharmacology. Drug Treatments
(56)
Animals
(50)
Female
(38)
Adult
(36)
Rats
(30)
Middle Aged
(19)
Area Under Curve
(17)
Immunomodulators
(17)
Administration, Oral
(16)
Antifungal Agents
(16)
Time Factors
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Tacrolimus - Pharmacokinetics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study

AmBisome (Liposomal Amphotericin B): A Comparative Review

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children

Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (Ambisome®) : A 91-day study in Rats

Demographic Considerations in Tacrolimus Pharmacokinetics

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a Liposomal amphotericin B formulation

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Withdrawal-Related Adverse Events from Clinical Trials of Clobazam in Lennox-Gastaut Syndrome (LGS) (P06.106)

Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic

The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

Lipid-based amphotericin B formulations: from animals to man

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Tacrolimus pharmacokinetics in BMT patients

Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose

Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse

Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients

FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse

Suchergebnisse filtern